IRS1 and Insulin resistance: Ex-4 was reported to improve neuronal insulin resistance both in vivo [50] and in vitro [15] experiments by preventing pathological phosphorylation of IRS-1, which interferes with its function to activate the downstream signaling cascade of insulin.